Sulfadoxine
- Generic Name
- Sulfadoxine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C12H14N4O4S
- CAS Number
- 2447-57-6
- Unique Ingredient Identifier
- 88463U4SM5
- Background
A long acting sulfonamide that is used, usually in combination with other drugs, for respiratory, urinary tract, and malarial infections.
- Indication
Sulfadoxine is used in combination with pyrimethamine for the treatment or prevention of malaria. It can also be used to treat various infections in livestock as well.
Sulfadoxine and pyrimethamine is indicated for the treatment of Plasmodium falciparum malaria in those patients in whom chloroquine resistance is suspected.
- Associated Conditions
- Malaria, Malaria caused by Plasmodium falciparum, Acute, uncomplicated Malaria caused by plasmodium falciparum
- Associated Therapies
- -
Perennial Malaria Chemoprevention (PMC) in Cameroon
- First Posted Date
- 2023-06-05
- Last Posted Date
- 2025-01-09
- Lead Sponsor
- London School of Hygiene and Tropical Medicine
- Target Recruit Count
- 2080
- Registration Number
- NCT05889052
- Locations
- 🇨🇲
Multiple, Soa and Mbankomo, Cameroon
Perennial Malaria Chemoprevention (PMC) in Côte D'Ivoire
- First Posted Date
- 2023-05-12
- Last Posted Date
- 2025-01-09
- Lead Sponsor
- London School of Hygiene and Tropical Medicine
- Target Recruit Count
- 1568
- Registration Number
- NCT05856357
- Locations
- 🇨🇮
Multiple, Séguéla, Côte D'Ivoire
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath